{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T14:28:11Z","timestamp":1744813691218},"reference-count":36,"publisher":"Portland Press Ltd.","issue":"1","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"abstract":"<jats:p>Ras oncoproteins are probably implicated in normal and malignant cell growth in various organs. Inhibition of Ras interferes with cell proliferation of non-hepatic cells in vitro and in vivo. A potential role for Ras in normal and malignant hepatocyte proliferation prompted us to evaluate the impact of Ras inhibition by FTS (S-farnesylthiosalicylic acid) on hepatocyte proliferation in vitro in the human hepatic tumour cell line HepG2 and in vivo after PH (partial hepatectomy) in rats. Rats were administered with FTS intraperitoneally (1, 8 and 16\u00a0h after PH) and killed 12, 24 and 48\u00a0h after PH. Cell proliferation, phosphorlyation of members of the MAPK (mitogen-activated protein kinase) pathway and levels and activity of cell cycle effectors (cyclin D, cyclin E, Cdk2 and Cdk4) were assessed in FTS-treated rats compared with controls. FTS significantly decreased overall cell count, PCNA (proliferating-cell nuclear antigen) expression and BrdU (bromodeoxyuridine) incorporation into HepG2 cells after 7\u00a0days of culture. FTS treatment significantly reduced BrdU incorporation and PCNA expression in hepatocytes after PH. Unlike control rats, cell-membrane expression of Ras was decreased in FTS-treated animals after PH, resulting in decreased Raf membrane recruitment and phosphorylation and in reduced phosphorylation of ERK1\/2 (extracellular-signal-regulated kinase 1\/2). The antiproliferative effect of FTS was linked to a decrease in expression and activity of the cyclin E\/Cdk2 complex, without affecting cyclin D and Cdk4. Ras inhibition by FTS significantly decreased proliferation of HepG2 cells and normal hepatocytes after a strong and highly synchronized proliferation stimulus elicited by PH. The inhibitory effect was at least partially mediated by inhibition of Ras\/Raf\/MAPK signalling. It appears worthwhile to evaluate the impact of Ras inhibition on the development of hepatocarcinomas in vivo in adequate animal models.<\/jats:p>","DOI":"10.1042\/cs20070152","type":"journal-article","created":{"date-parts":[[2007,11,30]],"date-time":"2007-11-30T16:11:23Z","timestamp":1196439083000},"page":"73-83","update-policy":"http:\/\/dx.doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Inhibition of the Ras oncoprotein reduces proliferation of hepatocytes <i>in vitro<\/i> and <i>in vivo<\/i> in rats"],"prefix":"10.1042","volume":"114","author":[{"given":"Alain","family":"da\u00a0Silva\u00a0Morais","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Catholic University of Louvain, St Luc University Hospital, 1200 Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Saliez","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Surgery, Catholic University of Louvain, St Luc University Hospital, 1200 Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Leclercq","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Catholic University of Louvain, St Luc University Hospital, 1200 Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Horsmans","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Catholic University of Louvain, St Luc University Hospital, 1200 Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"St\u00e4rkel","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Catholic University of Louvain, St Luc University Hospital, 1200 Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2007,11,30]]},"reference":[{"key":"2021120120531348100_B1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1146\/annurev.bi.62.070193.004223","article-title":"Function and regulation of ras","volume":"62","author":"Lowy","year":"1993","journal-title":"Annu. Rev. Biochem."},{"key":"2021120120531348100_B2","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1158\/1078-0432.CCR-06-1104","article-title":"Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer: a plan to move forward","volume":"12","author":"Kelloff","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"2021120120531348100_B3","doi-asserted-by":"crossref","first-page":"20608","DOI":"10.1074\/jbc.271.34.20608","article-title":"Cyclin D1 expression is regulated positively by the p42\/p44 MAPK and negatively by the p38\/HOG MAPK pathway","volume":"271","author":"Lavoie","year":"1996","journal-title":"J. Biol. Chem."},{"key":"2021120120531348100_B4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0014-4827(89)90058-X","article-title":"H-ras gene expressed at the G1 phase in primary cultures of hepatocytes","volume":"185","author":"Ikeda","year":"1989","journal-title":"Exp. Cell Res."},{"key":"2021120120531348100_B5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/jcp.1041440116","article-title":"Effect of epidermal growth factor on the expression of protooncogenes c-myc and c-Ha-Ras in short-term primary hepatocyte culture","volume":"144","author":"Kost","year":"1990","journal-title":"J. Cell. Physiol."},{"key":"2021120120531348100_B6","first-page":"5441","article-title":"Cellular ras activity is required for passage through multiple points of the G0\/G1 phase in BALB\/c 3T3 cells","volume":"14","author":"Dobrowolski","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"2021120120531348100_B7","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1128\/MCB.19.9.6003","article-title":"The mitogen-activated protein kinase\/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G1 phase progression in proliferating hepatocytes","volume":"19","author":"Talarmin","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"2021120120531348100_B8","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/hep.20969","article-title":"Liver regeneration","volume":"43","author":"Fausto","year":"2006","journal-title":"Hepatology"},{"key":"2021120120531348100_B9","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0955-0674(99)00044-7","article-title":"How do small GTPase signal transduction pathways regulate cell cycle entry?","volume":"11","author":"Marshall","year":"1999","journal-title":"Curr. Opin. Cell Biol."},{"key":"2021120120531348100_B10","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1126\/science.6297003","article-title":"Expression of cellular oncogenes during liver regeneration","volume":"219","author":"Goyette","year":"1983","journal-title":"Science"},{"key":"2021120120531348100_B11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/gut.49.1.119","article-title":"After portal branch ligation in the rat, cellular proliferation is associated with selective induction of c-Ha-ras, p53, cyclin E and cdk2","volume":"49","author":"St\u00e4rkel","year":"2001","journal-title":"Gut"},{"key":"2021120120531348100_B12","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/labinvest.3780343","article-title":"Expression of presumed specific early and late factors associated with liver regeneration in different rat surgical models","volume":"81","author":"Laurent","year":"2001","journal-title":"Lab. Invest."},{"key":"2021120120531348100_B13","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1038\/sj.onc.1204690","article-title":"Ras adenovirus modulate cyclin E protein expression and DNA synthesis after partial hepatectomy","volume":"20","author":"L\u00fcdde","year":"2001","journal-title":"Oncogene"},{"key":"2021120120531348100_B14","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1053\/j.gastro.2006.01.006","article-title":"Ubiquitous activation of ras and Jak\/Stat pathways in human HCC","volume":"130","author":"Calvisi","year":"2006","journal-title":"Gastroenterology"},{"key":"2021120120531348100_B15","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1038\/sj.onc.1209635","article-title":"Spreds, inhibitors of the Ras\/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors","volume":"25","author":"Yoshida","year":"2006","journal-title":"Oncogene"},{"key":"2021120120531348100_B16","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1073\/pnas.89.14.6403","article-title":"Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity","volume":"89","author":"Kato","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021120120531348100_B17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/(SICI)1097-0215(19990315)80:6<911::AID-IJC18>3.0.CO;2-4","article-title":"Growth inhibition of ras-dependent tumors in nude mice by a potent ras-dislodging antagonist","volume":"80","author":"Egozi","year":"1999","journal-title":"Int. J. Cancer"},{"key":"2021120120531348100_B18","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1021\/bi972032d","article-title":"Dislodgement and accelerated degradation of Ras","volume":"37","author":"Haklai","year":"1998","journal-title":"Biochemistry"},{"key":"2021120120531348100_B19","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1021\/jm00008a004","article-title":"Farnesyl derivatives of rigid carboxylic acids: inhibitors of ras-dependent cell growth","volume":"38","author":"Marciano","year":"1995","journal-title":"J. Med. Chem."},{"key":"2021120120531348100_B20","doi-asserted-by":"crossref","first-page":"22263","DOI":"10.1074\/jbc.270.38.22263","article-title":"Selective inhibition of Ras-dependent cell growth by farnesylthiosalicylic acid","volume":"270","author":"Marom","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2021120120531348100_B21","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1006\/bbrc.1997.7582","article-title":"The Ras antagonist S-farnesylthiosalicylic acid induces inhibition of MAPK activation","volume":"239","author":"Gana-Weisz","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021120120531348100_B22","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1038\/sj.onc.1202602","article-title":"A new functional Ras antagonist inhibits human pancreatic tumor growth in nude mice","volume":"18","author":"Weisz","year":"1999","journal-title":"Oncogene"},{"key":"2021120120531348100_B23","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0168-8278(99)80318-3","article-title":"The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats","volume":"31","author":"Reif","year":"1999","journal-title":"J. Hepatol."},{"key":"2021120120531348100_B24","first-page":"186","article-title":"Experimental pathology of the liver","volume":"12","author":"Higgins","year":"1931","journal-title":"Arch. Pathol."},{"key":"2021120120531348100_B25","doi-asserted-by":"crossref","first-page":"G302","DOI":"10.1152\/ajpgi.00175.2002","article-title":"Impaired Ras membrane association and activation in PPAR\u03b1 knockout mice after partial hepatectomy","volume":"284","author":"Wheeler","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2021120120531348100_B26","first-page":"645","article-title":"Use of 5-[76Br]bromo-2\u2032-fluoro-2\u2032-deoxyuridine as a ligand for tumour proliferation: validation in an animal tumour model","volume":"36","author":"Borbath","year":"2002","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"2021120120531348100_B27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0002-9440(10)63852-7","article-title":"Expression and DNA-binding activity of signal transducer and activator of transcription 3 in alcoholic cirrhosis compared to normal liver and primary biliary cirrhosis in humans","volume":"162","author":"St\u00e4rkel","year":"2003","journal-title":"Am. J. Pathol."},{"key":"2021120120531348100_B28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.1840150426","article-title":"Hepatocyte regeneration in acute fulminant and non-fulminant hepatitis: a study of proliferating cell nuclear antigen expression","volume":"15","author":"Wolf","year":"1992","journal-title":"Hepatology"},{"key":"2021120120531348100_B29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/383127a0","article-title":"Cell signalling. Raf gets it together","volume":"383","author":"Marshall","year":"1996","journal-title":"Nature"},{"key":"2021120120531348100_B30","first-page":"2503","article-title":"Mutational activation of c-raf-1 and definition of the minimal transforming sequence","volume":"10","author":"Heidecker","year":"1990","journal-title":"Mol. Cell. Biol."},{"key":"2021120120531348100_B31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1042\/bst0270363","article-title":"Small GTPases and cell cycle regulation","volume":"27","author":"Marshall","year":"1999","journal-title":"Biochem. Soc. Trans."},{"key":"2021120120531348100_B32","doi-asserted-by":"crossref","first-page":"23589","DOI":"10.1074\/jbc.270.40.23589","article-title":"Transforming p21 ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions","volume":"270","author":"Albanese","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2021120120531348100_B33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0960-9822(97)70094-0","article-title":"Ras signalling is required for inactivation of the tumor suppressor pRb cell-cycle control protein","volume":"7","author":"Mittnacht","year":"1997","journal-title":"Curr. Biol."},{"key":"2021120120531348100_B34","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1535-7163.MCT-06-0706","article-title":"Supression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid)","volume":"6","author":"Zundelevich","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"2021120120531348100_B35","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/labinvest.3700245","article-title":"Blunted DNA synthesis and delayed S-phase entry following inhibition of Cdk2 activity in the regenerating rat liver","volume":"85","author":"St\u00e4rkel","year":"2005","journal-title":"Lab. Invest."},{"key":"2021120120531348100_B36","first-page":"3111","article-title":"Sequential protooncogene expression during rat liver regeneration","volume":"46","author":"Thompson","year":"1986","journal-title":"Cancer Res."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/114\/1\/73\/438683\/cs1140073.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/114\/1\/73\/438683\/cs1140073.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T22:09:13Z","timestamp":1638396553000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/114\/1\/73\/68515\/Inhibition-of-the-Ras-oncoprotein-reduces"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,30]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20070152","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,30]]}}}